STUART A. RANDLE - 14 Feb 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.

Role
Director
Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
Issuer symbol
CMRA on OTC
Transactions as of
14 Feb 2023
Net transactions value
$0
Form type
4
Filing time
16 Feb 2023, 17:32:00 UTC
Previous filing
14 Feb 2023
Next filing
14 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRA Stock Option (Right to Purchase) Award $0 +7,100 $0.000000 7,100 14 Feb 2023 Common Stock 7,100 $1.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in 12 equal monthly installments beginning on March 14, 2023 such that the option will be fully vested on February 14, 2024, subject to continuous service to the issuer through each vesting date.